This page — “SCHD International Exposure” — is for non-US or globally diversified investors who need clarity on how SCHD applies to their situation.
This isn't formal cross-border tax advice — rules vary by country, so confirm specifics with a local professional.
Comprehensive analysis of SCHD's international revenue exposure. Understand geographic diversification, currency risks, and global market correlations of SCHD's underlying holdings.
While SCHD is a U.S.-focused dividend ETF, its underlying companies generate significant revenue from international markets. This indirect international exposure provides global diversification while maintaining the U.S. regulatory and tax framework that investors prefer.
This analysis examines the geographic revenue distribution, currency exposures, and global market correlations of SCHD's portfolio, providing insights into its true international diversification characteristics.
SCHD's international revenue is concentrated in developed markets, with significant exposure to Europe and Asia-Pacific regions. This distribution provides natural currency and economic diversification.
Key Insight: The companies with highest international revenue exposure in SCHD are typically in sectors like Healthcare (pharmaceuticals), Technology (semiconductors), and Industrials (global machinery). These companies benefit from global scale while providing U.S. investors with international diversification through familiar, well-regulated U.S. corporations.
International revenue exposure creates natural currency diversification. SCHD's holdings have significant exposure to major global currencies, providing a hedge against U.S. dollar strength.
Correlation Insight: While SCHD provides international revenue diversification, its market correlation remains highest with U.S. markets. This makes sense given that company headquarters, management, and primary listings are all in the United States. The international exposure provides economic diversification more than market diversification.